Shire

company

About

Shire biotechnology company that focuses on serving people with rare diseases.

  • 10001 - max

Details

Industries
Biopharma,Biotechnology,Genetics,Health Care,Therapeutics,Wellness
Founded date
Jan 1, 1986
Number Of Employee
10001 - max
Operating Status
Active

Shire is the leading global biotechnology company focused on serving people with rare diseases. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.

At Shire, the company ground everything they do in their purpose of enabling people with life altering conditions to lead better lives. The company's patient and customer focused culture encourages employees to embrace innovation and challenge the status quo through respectful and inclusive engagement with colleagues. Honesty and transparency are inherent in all that we do as we work with a high sense of urgency to become a leading global biotech delivering innovative therapies to patients with rare diseases and other specialty conditions. We foster an environment where leaders are positive, accountable, results driven and great people managers. Our employees own their development in partnership with their manager, understand and leverage their strengths, bring their whole selves to work, and like the leaders they are expected to eventually become, share the essential traits of positive, accountable and results driven. Our non-hierarchical structure and clear reporting lines enable quick decision making, nimble execution and the opportunity for employees to enjoy the work and grow to their fullest potential.

The company is committed to recruit, develop and retain top talent who take a responsible and ethical approach to all that we do and who want to make a difference in the lives of patients across the globe.

Investments

Number of Investments
Number of Lead Investments
1
1
Shire has made 1 investments. Their most recent investment was on Feb 7, 2018, when Rani Therapeutics raised $53M.
Date Company Name
Round Money Raised Industry Lead Investor
Series Unknown $53M Biotechnology Yes